This is the bone-and-joint decade, and it certainly could be considered the bone-and-joint imaging decade as well because there have been many advances and changes in imaging — diagnostic and therapeutic imaging — that are directly relevant to musculoskeletal. While there are exciting things going on in radiography, ultrasound, CT, etc., I will focus today on MRI. Functional imaging cuts across all of these modalities. Flexion-extension radiographs, dynamic ultrasound, and kinematic MRI should all be considered part of functional imaging in the broad sense. We’ll talk about what clinicians need to know when they are looking at MRI imaging to evaluate patients with rheumatologic conditions.

Originally posted here:
Rheumatology Rounds : Advances in Musculoskeletal Imaging: Rheumatology

Older person with rheumatoid arthritis (RA) make up an increasing proportion of those treated with biologic disease modifying anti-rheumatic agents (DMARDs). The safety of these agents may differ for this subgroup of older RA patients, yet effects have generally not been selectively studied in this population. Here, Schneeweis et al (Arthritis Rheum 2007; 56: 1754) explore the association of TNF inhibitor therapy and serious bacterial infection in RA patients 65 years of age or older.

The rest is here:
Prednisone, but not TNF inhibitors, is associated with an increased risk of serious infection in older RA patients

180+ Verified Appraisal Management Companies With Additional Chapters On Recession Proofing Your Business, Appraisal Company Marketing And More. National Appraisal Management Company Directory.

Read more:
Appraisal Management Company Directory 2009

Individuals with rheumatoid arthritis (RA) are at an increased risk for lymphoma compared to the general population, with the risk increasing in proportion to cumulative exposure to systemic inflammation. Whether RA therapies, such as biologic and non-biologic DMARDs, contribute to this risk is controversial.

Here is the original post:
No Link Between RA Therapy and Lymphoma Observed in Large Cohort of Rheumatoid Arthritis Patients

Individuals with rheumatoid arthritis (RA) are at an increased risk for lymphoma compared to the general population, with the risk increasing in proportion to cumulative exposure to systemic inflammation. Whether RA therapies, such as biologic and non-biologic DMARDs, contribute to this risk is controversial.

See the rest here:
No Link Between RA Therapy and Lymphoma Observed in Large Cohort of Rheumatoid Arthritis Patients